">

Transplant Lab Analysis and Management Software

Enabling you to deliver reliable test results with greater confidence and ease

Our portfolio of software applications aid in the analysis and evaluation of data generated with our HLA typing, MICA, KIR, and antibody detection tests. Assisting with the assignment of typing and antibody detection results, our software can further increases testing efficiency.

Software that increases testing efficiency

HistoTrac Core software

HistoTrac Core services

HLA analysis software

Streamline data access with our software

HistoTrac Core software

The HistoTrac Core software is a widely used tool in transplant laboratories, organ procurement organizations and blood centers for donor and patient management.

HistoTrac Lite software

The HistoTrac Lite software is an affordable ready to use laboratory management system to effortlessly manage patient, sample, and test data and is integrated with One Lambda branded products.

HLA Fusion software

Powerful analysis modules are specifically designed to be utilized with One Lambda molecular and antibody assays.

HLA Fusion research software

Used for easy analysis of molecular typing and antibody screening results. Designed to support One Lambda research use only products.

SureTyper

Analyse LinkSēq HLA products with this software that is simple, fast, automated, and requires minimal training.

SureTyper Blood

Analyse LinkSēq ABO and HPA products with this software that is simple, fast, automated, and requires minimal training.

TypeStream Visual NGS Analysis

Provides automated and streamlined analysis of One Lambda AllType NGS products with a wide range of analytical tools, run statistics and quality metrics to facilitate examination and reinforce decision making.

uTYPE HLA Sequence Analysis

Used for analysis of SeCore HLA sequence-based typing (SBT) products.


Need analysis results you can trust? Choose the solution that best fits your lab


Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.

">